Posts tagged WellPoint
Push-back on costs of cancer drugs. WellPoint is increasing the amount it pays for less expensive generic cancer drugs as an incentive for doctors to use them.
WellPoint Slowly Implementing its Diversification Strategy. WellPoint announced plans to buy contact-lens and eyewear retailer 1-800 Contacts Inc.
Anthem Blue Cross, Aetna and other health insurers are increasingly shifting more prescriptions for complex conditions to a new category requiring customers to shoulder a larger share of the medication’s cost.
What were they complaining about? Insurance companies spent millions of dollars trying to defeat the U.S. health-care overhaul, saying it would raise costs and disrupt coverage. Instead, profit margins at the companies widened to levels not seen since before the recession, a Bloomberg Government study shows.
WellPoint continues Medicare push
WellPoint agreed to acquire CareMore, a privately held provider of health plans and services for senior citizens, an area of focus for the company. Read more here
